Agile Therapeutics reported -1424000 in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Adma Biologics ADMA:US $ 0.38M 1.39M
Agile Therapeutics AGRX:US -1424000 1.46M
Bayer BAYN:GR 5.89B 414M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Johnson & Johnson JNJ:US $ 16088M 343M
Merk MRK:US $ 10098M 1738M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Pfizer PFE:US $ 14163M 2178M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M
Therapeuticsmd TXMD:US 20.12M 1.25M